Josh White

Chief Commercial Officer (CCO) at CoapTech | Washington, District of Columbia, United States

About Josh White

As the Vice President of Strategy & Business Development at Sonnest, Inc., Josh White leverages over two decades of extensive experience in the healthcare sector to drive innovative solutions in cardiac ultrasound imaging. His leadership is pivotal in the development and commercialization of Electrast™, a groundbreaking voltage-activated ultrasound imaging drug designed to enhance the evaluation of myocardial perfusion. This innovative product operates in an inactive state, allowing for precise activation within the heart, thereby enabling clinicians to conduct rapid and cost-effective assessments of cardiac health.

Josh's expertise spans various domains, including medical devices, strategic planning, and market development, making him a key player in navigating the complexities of the healthcare landscape. His strategic vision is complemented by a robust background in product development and launch, ensuring that Sonnest not only meets regulatory standards but also addresses the evolving needs of healthcare providers and patients alike. By fostering stakeholder engagement and cultivating partnerships, Josh is instrumental in positioning Electrast™ as a transformative tool in cardiac diagnostics.

In his role, Josh is also focused on identifying new market opportunities and driving growth strategies that align with the company's mission to improve patient outcomes. His entrepreneurial spirit and commitment to innovation are evident in his approach to business development, where he emphasizes collaboration and forward-thinking solutions. As Sonnest, Inc. continues to advance its pioneering technologies, Josh White remains at the forefront, dedicated to reshaping the future of cardiac imaging and enhancing the quality of care in the healthcare industry.

Josh White Work